DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Halozyme Therapeutics, Inc. (HALO)
« Back to company indexHALO Chatter Timeline
Stock Ticker for HALO
Most Active Tweeters for HALO
| User | Tweets |
|---|---|
| @bilalv87 | 3 |
| @Tickeron | 3 |
| @iamToddyTickles | 2 |
| @Wattwurm73 | 2 |
| @TickerReport | 2 |
Recent Tweets for HALO
 |
@bilalv87 RT @iamToddyTickles: Kiran Sidhu is as smart, genuine and relatable as CEO’s come. $HALO @halolabsinc https://t.co/6n7d1lr1x1 11:09am |
|
@bilalv87 RT @iamToddyTickles: $HALO working with Caliva who has partnered with the one and only Mr. Shawn Carter (yes) JAY-Z!! ? ? https://t.co/3Sv7… 11:09am |
 |
@iamToddyTickles $HALO working with Caliva who has partnered with the one and only Mr. Shawn Carter (yes) JAY-Z!! ? ? https://t.co/3Sv71zO76Q 9:09am |
 |
@SandFlorentin RT @halolabsinc: CEO of $HALO Kiran Sidhu sits down with @iamToddyTickles on SiriusXM Canada to discuss legalization and supply agreement w… 7:09am |
 |
@Biotech2050 RT @Wattwurm73: $HALO Roche Pharma Day slide 46 showing Herceptin + Perjeta FDC SC (Enhanze) significant time savings administration IV vs… 6:09am |
 |
@Wattwurm73 $HALO Roche Pharma Day slide 46 showing Herceptin + Perjeta FDC SC (Enhanze) significant time savings administratio… https://t.co/GGsEC7c2mA 4:09am |
 |
@Tickeron $HALO's Aroon indicator reaches into Uptrend on September 13, 2019. View odds for this and other indicators:… https://t.co/SBAVFyV7ag 4:09am |
 |
@halolabsinc CEO of $HALO Kiran Sidhu sits down with @iamToddyTickles on SiriusXM Canada to discuss legalization and supply agre… https://t.co/loFLFRk0ZL September 15th 2019, 6:09pm |
|
@iamToddyTickles Kiran Sidhu is as smart, genuine and relatable as CEO’s come. $HALO @halolabsinc https://t.co/6n7d1lr1x1 September 15th 2019, 3:09pm |
 |
@biotechw2019 $HALO is making a higher low ascending triangle since the gap total filled ! https://t.co/RMxfVsYamj September 15th 2019, 1:09pm |
 |
@FirstRareBooks @endpts @dhovekamp42 $HALO makes that recently approved IV Tecentriq Combination for NSCLC Subcutaneous https://t.co/VGMgJhu7C7 September 15th 2019, 12:09pm |
 |
@ShaaRedNL $HALO Liking their ECM degradation technology. Stock should be valued much higher. Looking to add next week. https://t.co/bwAXO08I88 September 14th 2019, 4:09pm |
 |
@ZolmaxNews Halozyme Therapeutics $HALO Downgraded to “Hold” at ValuEngine https://t.co/uvMUIh2A3r September 14th 2019, 5:09am |
 |
@CompoundStock13 RT @lastprince416: Halo Labs Signs Bulk Extract Supply Agreement With Caliva $HALO #NEOexchange #USMSO #potstocks #weedstocks https://t.co… September 13th 2019, 9:09pm |
 |
@mmjinvesting Reason for the full session halt on @halolabsinc $HALO Halo Labs Inc. has entered into a bulk supply agreement wit… https://t.co/Zy2MtN7SfR September 13th 2019, 6:09pm |
|
@Tickeron $HALO's Aroon indicator reaches into Uptrend on September 12, 2019. View odds for this and other indicators:… https://t.co/hlxEAK2jOj September 13th 2019, 5:09pm |
 |
@jimrockfordatSH RT @TheDeepDive_ca: $HALO halted pending news September 13th 2019, 5:09pm |
 |
@junglejava1 Halo Signs Bulk Extract Supply Agreement With Caliva $HALO https://t.co/09bpY9C7ch September 13th 2019, 5:09pm |
 |
@lastprince416 Halo Labs Signs Bulk Extract Supply Agreement With Caliva $HALO #NEOexchange #USMSO #potstocks #weedstocks https://t.co/OLAtmg3YbK September 13th 2019, 5:09pm |
 |
@MaisaCorp $HALO phase 3 FeDeriCa study evaluating a fixed-dose subcutaneous combination of two breast cancer drugs using the… https://t.co/p9o3WO9D2s September 13th 2019, 4:09pm |
|
@bilalv87 RT @ToddShapiroShow: "Legalization - Everyone Looking To Be Part Of Movement" #HaloLabs' Kiran Sidhu w/ @iamToddyTickles $HALO https://t.co… September 13th 2019, 2:09pm |
 |
@ToddShapiroShow "Legalization - Everyone Looking To Be Part Of Movement" #HaloLabs' Kiran Sidhu w/ @iamToddyTickles $HALO https://t.co/Oxtq4LokRA September 13th 2019, 1:09pm |
 |
@TheDeepDive_ca $HALO halted pending news September 13th 2019, 12:09pm |
 |
@TickerReport Halozyme Therapeutics $HALO Rating Lowered to Hold at ValuEngine https://t.co/Bq96neqF8g September 13th 2019, 10:09am |
 |
@ABiggzHD Hit that Notification! Here is my Pre-Market Watchlist and game plan! $PCG - 11bln Settlement $HALO - Positive Re… https://t.co/hkZ9aqGHoG September 13th 2019, 9:09am |
 |
@BankTheTrade $HALO(16.49) up 1.40 said pre-market Friday that a phase 3 FeDeriCa study evaluating a fixed-dose subcutaneous comb… https://t.co/LHIN0y59j8 September 13th 2019, 8:09am |
 |
@Briefingcom $HALO: Halozyme Therapeutics reports Phase III FeDeriCa study met primary endpoint of non-inferiority https://t.co/mxMFVrcgFK September 13th 2019, 8:09am |
 |
@newswelldone $HALO: Halozyme reports positive results from Perjeta + Herceptin …: https://t.co/1OGoSGZ8Ng September 13th 2019, 7:09am |
 |
@MarketCurrents $HALO - Halozyme reports positive results from Perjeta + Herceptin combination study https://t.co/rItogbncP8 September 13th 2019, 7:09am |
 |
@alertdata3 RT @BioStocks: $HALO Global Phase 3 FeDeriCa Study Conducted By Genentech Met Its Primary Endpoint. https://t.co/yD5OYAtY5Z $RHHBY September 13th 2019, 7:09am |
 |
@BioStocks $HALO Global Phase 3 FeDeriCa Study Conducted By Genentech Met Its Primary Endpoint. https://t.co/yD5OYAtY5Z $RHHBY September 13th 2019, 6:09am |
 |
@Gambiste1 RT @Wattwurm73: $CTMX $HALO BMY CEO at MS conference (min 29), data on next gen CTLA-4s next year, primarily phase 1 September 13th 2019, 6:09am |
 |
@newsfilterio $HALO Halozyme Therapeutics announced that the... https://t.co/JKi8TUPDDe September 13th 2019, 1:09am |
|
@Biotech2050 RT @Wattwurm73: $HALO Perjeta + Herceptin Fixed Dose SC combo (Enhanze) phase 3 results, primary endpoint non-inferiority met. https://t.co… September 13th 2019, 1:09am |
 |
@StockNewsWires $HALO: Positive Results Announced From Phase 3 Trial Evaluating Fixed …: https://t.co/3Rye9cZmrz September 13th 2019, 1:09am |
|
@Wattwurm73 $HALO Perjeta + Herceptin Fixed Dose SC combo (Enhanze) phase 3 results, primary endpoint non-inferiority met. https://t.co/NiCAaseXMy September 13th 2019, 1:09am |
 |
@VisualStockRSRC $HALO - Positive Results Announced From Phase 3 Trial Evaluating Fixed-Dose Subcutaneous Combination Of https://t.co/WqfWfVjo1z September 13th 2019, 1:09am |
 |
@iamtito_ $HALO - Positive Results Announced From Phase 3 Trial Evaluating Fixed-Dose Subcutaneous Combination Of https://t.co/SjSLbC1mBh September 13th 2019, 1:09am |
|
@Tickeron $HALO's Aroon indicator reaches into Uptrend on September 11, 2019. View odds for this and other indicators:… https://t.co/Ei0hZkgxAv September 12th 2019, 3:09pm |
 |
@ConsumerFeed Halozyme Therapeutics $HALO Downgraded by ValuEngine https://t.co/9hQcVIArPb September 12th 2019, 1:09pm |
|
@TickerReport Halozyme Therapeutics, Inc. $HALO Receives Consensus Recommendation of “Hold” from Analysts https://t.co/Hyfln8Zr8d September 12th 2019, 11:09am |
 |
@AmericanBanking Halozyme Therapeutics, Inc. $HALO Receives Consensus Recommendation of “Hold” from Analysts https://t.co/slEtZqHqA1 #stocks September 12th 2019, 11:09am |
 |
@stocknewstimes Halozyme Therapeutics, Inc. $HALO Receives Consensus Recommendation of “Hold” from Analysts https://t.co/nPY1xKHdtW September 12th 2019, 11:09am |
 |
@dispatchtribune Halozyme Therapeutics $HALO Rating Increased to Hold at Zacks Investment Research https://t.co/SXca0e3kPs August 11th 2019, 3:08pm |
 |
@OlympiaReport Halozyme Therapeutics $HALO Rating Increased to Hold at Zacks Investment Research https://t.co/yFqvpupRiU August 11th 2019, 3:08pm |
|
@Tickeron $HALO in Uptrend: 50-day Moving Average moved above 200-day Moving Average on July 23, 2019. View odds for this and… https://t.co/5Ug4vabfAl August 11th 2019, 1:08pm |
|
@TickerReport Q3 2019 EPS Estimates for Halozyme Therapeutics, Inc. $HALO Boosted by Piper Jaffray Companies https://t.co/x45tenNz9i August 11th 2019, 2:08am |
|
@TickerReport Jefferies Financial Group Equities Analysts Boost Earnings Estimates for Halozyme Therapeutics, Inc. $HALO https://t.co/zXPy7Vp9xu August 11th 2019, 2:08am |
|
@ConsumerFeed Q3 2019 EPS Estimates for Halozyme Therapeutics, Inc. $HALO Boosted by Piper Jaffray Companies https://t.co/MF2eYyFzG1 August 11th 2019, 1:08am |
 |
@WatchlistN Halozyme Therapeutics $HALO Rating Increased to Hold at Zacks Investment Research https://t.co/5c1xTyifQ0 August 10th 2019, 6:08pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.